Pfizer Acquires a Stem-Cell Therapy

Pfizer said Sunday that it was buying the rights to a somewhat controversial cell therapy from Athersys, a biotechnology company — a sign of big pharmaceutical companies’ growing interest in stem cells.

Pfizer will have the rights to develop Athersys’s cells to treat inflammatory bowel disease, the companies are expected to announce on Monday. It will pay Athersys $6 million initially and up to $105 million in the future.

read more:

Incoming search terms:

stemgenex complaints, stemgenex reviews, stemgenex cost, stem genex reviews, stemgenex review, is stem genex reviews, StemGenex™, stemgenex fraud, how much does stemgenex cost, stem genex legitimate, scams stemgenex, what s wrong with stemgenex.
Recent Related Posts